| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Lantern Pharma Inc. (LTRN) has 8 insiders with recent SEC Form 4 filings, including 1 buy and 24 sells. LTRN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 28.8K | $114.7K | - | |
| Dir | 25.0K | $99.4K | - | |
| Dir | 25.0K | $99.4K | - | |
| Dir | 25.0K | $99.4K | - | |
| Dir | 25.0K | $99.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 17, 2024 | Kreis Leslie W.48 | 10% Owner | Sell | 58,889 | $4.20 | $247,333.80 | -6.9% | +60.9% | -3.5% | |
| Jan 17, 2024 | Fletcher Aaron G.L.50 | 10% Owner | Sell | 58,889 | $4.20 | $247,333.80 | -6.9% | +60.9% | -3.5% | |
| Nov 29, 2023 | Kreis Leslie W.48 | 10% Owner | Sell | 145,348 | $3.44 | $499,997.12 | -19.8% | +15.1% | -17.9% | |
| Nov 29, 2023 | Fletcher Aaron G.L.50 | 10% Owner | Sell | 145,348 | $3.44 | $499,997.12 | -19.8% | +15.1% | -17.9% | |
| Nov 8, 2022 | Fletcher Aaron G.L.50 | 10% Owner | Sell | 350,000 | $4.40 | $1,540,000.00 | -18.8% | +36.7% | -36.2% | |
| Nov 8, 2022 | Kreis Leslie W.48 | 10% Owner | Sell | 350,000 | $4.40 | $1,540,000.00 | -18.8% | +36.7% | -36.2% | |
| Sep 2, 2022 | Kreis Leslie W.48 | 10% Owner | Sell | 6,445 | $5.20 | $33,514.00 | -12.1% | -3.8% | -10.4% | |
| Sep 2, 2022 | Fletcher Aaron G.L.50 | 10% Owner | Sell | 6,445 | $5.20 | $33,514.00 | -12.1% | -3.8% | -10.4% | |
| Jun 11, 2020 | Keyser D Jeffrey | Director | Buy | 10,000 | $15.00 | $150,000.00 | New | - | - |